Viewing StudyNCT00421213



Ignite Creation Date: 2024-05-05 @ 5:17 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00421213
Status: COMPLETED
Last Update Posted: 2012-07-19
First Post: 2007-01-10

Brief Title: Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
Sponsor: Alaunos Therapeutics
Organization: Alaunos Therapeutics

Conditions & Keywords Data

Conditions:
Name
Non-Hodgkins Lymphoma
Hematologic Neoplasms
Bone Marrow Neoplasms
Keywords:
Name View
APL View
Lymphoma View
T-cell Lymphoma View
Peripheral T-cell Lymphoma View